Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
RVPH · Form 25-NSE · REVIVA PHARMACEUTICALS HOLDINGS, INC. | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 77 · 7,646 total
HCA: 8-K · earnings release
HCA · 8-K · 2026-10-27
SPGI: 8-K · earnings release
SPGI · 8-K · 2026-10-27
IPHA: 6-K · clinical trial
IPHA · 6-K · 2026-10-27
PHAR: 6-K · earnings release
PHAR · 6-K · 2026-10-27
IQV: 8-K · earnings release
IQV · 8-K · 2026-10-27
GWRE: 8-K · acquisition merger
GWRE · 8-K · 2026-10-27
CNL: 6-K · clinical trial
CNL · 6-K · 2026-10-27
GLXY: 8-K · earnings release
GLXY · 8-K · 2026-10-27
SHW: 8-K · earnings release
SHW · 8-K · 2026-10-27
RGEN: 8-K · earnings release
RGEN · 8-K · 2026-10-27
AMT: 8-K · earnings release
AMT · 8-K · 2026-10-27
SOFI: 8-K · earnings release
SOFI · 8-K · 2026-10-27
ABG: 8-K · earnings release
ABG · 8-K · 2026-10-27
VBNK: 6-K · regulatory action
VBNK · 6-K · 2026-10-27
IAG: 6-K · other
IAG · 6-K · 2026-10-27
SMPL: 8-K · earnings release
SMPL · 8-K · 2026-10-27
PYPL: 8-K · earnings release
PYPL · 8-K · 2026-10-27
MRX: 6-K · leadership change
MRX · 6-K · 2026-10-27
GLW: 8-K · earnings release
GLW · 8-K · 2026-10-27
XYL: 8-K · earnings release
XYL · 8-K · 2026-10-27
IVZ: 8-K · earnings release
IVZ · 8-K · 2026-10-27
JAKK: 10-Q · periodic report
JAKK · 10-Q · 2026-10-27
AWI: 10-Q · periodic report
AWI · 10-Q · 2026-10-27
SNDL: 6-K · earnings release
SNDL · 6-K · 2026-10-27
ODV: 6-K · other
ODV · 6-K · 2026-10-27
CSHR: 6-K · share repurchase
CSHR · 6-K · 2026-10-27
MSCLF: 6-K · other
MSCLF · 6-K · 2026-10-27
KO: 8-K · earnings release
KO · 8-K · 2026-10-27
JCI: 8-K · earnings release
JCI · 8-K · 2026-10-27
PNR: 8-K · earnings release
PNR · 8-K · 2026-10-27
AZN: 6-K · fda approval
AZN · 6-K · 2026-10-27
RTO: 6-K · share repurchase
RTO · 6-K · 2026-10-27
MFIC: 8-K · acquisition merger
MFIC · 8-K · 2026-10-27
IVZ: 8-K · debt financing
IVZ · 8-K · 2026-10-27
CMS: 8-K · earnings release
CMS · 8-K · 2026-10-27
YMT: 424B3 · reverse split
YMT · 424B3 · 2026-10-27
FER: 6-K · material agreement
FER · 6-K · 2026-10-27
HRI: 10-Q · periodic report
HRI · 10-Q · 2026-10-27
YMT: 6-K · reverse split
YMT · 6-K · 2026-10-27
VRT: 8-K · acquisition merger
VRT · 8-K · 2026-10-27
CPAC: 6-K · earnings release
CPAC · 6-K · 2026-10-27
RCL: 8-K · earnings release
RCL · 8-K · 2026-10-27
GM: 8-K · delisting
GM · 8-K · 2026-10-27
SHG: 6-K · share repurchase
SHG · 6-K · 2026-10-27
ARCC: 10-Q · periodic report
ARCC · 10-Q · 2026-10-27
FHN: 8-K · leadership change
FHN · 8-K · 2026-10-27
IMNN: S-1 · offering registration
IMNN · S-1 · 2026-10-27
CNP: 8-K · earnings release
CNP · 8-K · 2026-10-27
TRU: 8-K · earnings release
TRU · 8-K · 2026-10-27
AB: 8-K · earnings release
AB · 8-K · 2026-10-27
BIDU: 6-K · earnings release
BIDU · 6-K · 2026-10-27
BBVA: 6-K · regulatory action
BBVA · 6-K · 2026-10-27
ARCC: 8-K · earnings release
ARCC · 8-K · 2026-10-27
SHG: 6-K · share repurchase
SHG · 6-K · 2026-10-27
ARCC: 8-K · acquisition merger
ARCC · 8-K · 2026-10-27
SHG: 6-K · earnings release
SHG · 6-K · 2026-10-27
IX: 6-K · other
IX · 6-K · 2026-10-27
NVS: 6-K · earnings release
NVS · 6-K · 2026-10-27
HCM: 6-K · clinical trial
HCM · 6-K · 2026-10-27
ACRS: 8-K · clinical trial
ACRS · 8-K · 2026-10-27
UPS: 8-K · earnings release
UPS · 8-K · 2026-10-27
HYMC: 8-K · earnings release
HYMC · 8-K · 2026-10-27
ING: 6-K · share repurchase
ING · 6-K · 2026-10-27
EQNR: 6-K · share repurchase
EQNR · 6-K · 2026-10-27
CNP: 10-Q · periodic report
CNP · 10-Q · 2026-10-27
WDS: 6-K · asset sale
WDS · 6-K · 2026-10-27
HLT: 8-K · earnings release
HLT · 8-K · 2026-10-27
IONR: 6-K · periodic report
IONR · 6-K · 2026-10-27
VBIO: 8-K · material agreement
VBIO · 8-K · 2026-10-27
IBCP: 8-K · earnings release
IBCP · 8-K · 2026-10-27
PG: 424B5 · prospectus supplement
PG · 424B5 · 2026-10-27
AWI: 8-K · earnings release
AWI · 8-K · 2026-10-27
NMR: 6-K · foreign private issuer
NMR · 6-K · 2026-10-27
ATAT: 6-K · other
ATAT · 6-K · 2026-10-27
TII: 6-K · other
TII · 6-K · 2026-10-27
REXR: 10-Q · periodic report
REXR · 10-Q · 2026-10-27
WETO: 6-K · amendment
WETO · 6-K · 2026-10-27
CNC: 10-Q · periodic report
CNC · 10-Q · 2026-10-26
CPAC: 6-K · earnings release
CPAC · 6-K · 2026-10-26
CNC: 8-K · earnings release
CNC · 8-K · 2026-10-26
BMOOF: 6-K · material agreement
BMOOF · 6-K · 2026-10-26
ELE: 6-K · acquisition merger
ELE · 6-K · 2026-10-26
BETR: 8-K · leadership change
BETR · 8-K · 2026-10-26
NAUT: 8-K · earnings release
NAUT · 8-K · 2026-10-26
CMTV: 8-K · earnings release
CMTV · 8-K · 2026-10-26
PII: 8-K · earnings release
PII · 8-K · 2026-10-26
EGO: 6-K · other
EGO · 6-K · 2026-10-26
BFH: 10-Q · periodic report
BFH · 10-Q · 2026-10-26
ELP: 6-K · leadership change
ELP · 6-K · 2026-10-26
POAS: 6-K · other
POAS · 6-K · 2026-10-26
AMGN: 8-K · leadership change
AMGN · 8-K · 2026-10-26
BCSF: 8-K · earnings release
BCSF · 8-K · 2026-10-26
HYMC: 10-Q · periodic report
HYMC · 10-Q · 2026-10-26
BLX: 6-K · dividend
BLX · 6-K · 2026-10-26
VLRS: 6-K · earnings release
VLRS · 6-K · 2026-10-26
SNDL: 6-K · earnings release
SNDL · 6-K · 2026-10-26
AURE: SCHEDULE 13D/A · ownership disclosure
AURE · SCHEDULE 13D/A · 2026-10-27
GRML: S-1 · offering registration
GRML · S-1 · 2026-10-26
BEAG: 8-K · other
BEAG · 8-K · 2026-10-26
IQST: 8-K · debt financing
IQST · 8-K · 2026-10-26
1
2
3
4
8
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
76
77
Next ›
